Etanercept Clearance during an in vitro Model of Continuous Venovenous Hemofiltration

Publisher： Karger

E-ISSN： 1421-9735|28|4|348-353

ISSN： 0253-5068

Source： Blood Purification, Vol.28, Iss.4, 2009-09, pp. : 348-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How to Calculate Clearance of Highly Protein-Bound Drugs during Continuous Venovenous Hemofiltration Demonstrated with Flucloxacillin

By  

Kidney and Blood Pressure Research, Vol. 26, Iss. 2, 2003-06 ,pp. : 135-140

Karger

Access to resources Recommend Favorite

Cytokine Removal in Septic Patients with Continuous Venovenous Hemofiltration

By  

Kidney and Blood Pressure Research, Vol. 26, Iss. 2, 2003-06 ,pp. : 128-134

Karger

Access to resources Recommend Favorite

Cellulose Triacetate Dialyzer Reduces Platelet Loss during Continuous Veno-Venous Hemofiltration

By  

Blood Purification, Vol. 29, Iss. 4, 2010-05 ,pp. : 375-382

Karger

Access to resources Recommend Favorite

Citrate Formulation Determines Filter Lifespan during Continuous Veno-Venous Hemofiltration: A Prospective Cohort Study

By  

Blood Purification, Vol. 40, Iss. 3, 2015-0 ,pp. : 194-202

Karger

Access to resources Recommend Favorite

Peripheral Perfusion Index Predicts Hypotension during Fluid Withdrawal by Continuous Veno-Venous Hemofiltration in Critically Ill Patients

By  

Blood Purification, Vol. 40, Iss. 1, 2015-06 ,pp. : 92-98

Karger

Access to resources Recommend Favorite